UB Paderborn / Katalog / Suche / in CDI

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

Psychopharmacology, 2013-01, Vol.225 (1), p.1-19

2013

Link zum Volltext

Verfügbarkeit prüfen

An update of safety of clinically used atypical antipsychotics

Expert opinion on drug safety, 2016-10, Vol.15 (10), p.1329-1347

2016

Link zum Volltext

Verfügbarkeit prüfen

Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder

Neuropharmacology, 2017-07, Vol.121, p.179-194

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients

Journal of affective disorders, 2018-03, Vol.228, p.118-124

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression

Journal of psychiatric research, 2021-04, Vol.136, p.522-528

2021

Link zum Volltext

Verfügbarkeit prüfen

A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

Translational psychiatry, 2015-02, Vol.5 (2), p.e512-e512

2015

Link zum Volltext

Verfügbarkeit prüfen

Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis

Current pharmaceutical design, 2005-10, Vol.11 (27), p.3561

2005

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Homer1a expression levels as a tool to investigate antipsychotic-related perturbation of synaptic plasticity: translational implications for schizophrenia treatment strategies

European neuropsychopharmacology, 2016-10, Vol.26, p.S233-S233

2016

Link zum Volltext

Verfügbarkeit prüfen

Haloperidol modulates functional connectivity in the glutamate system: a postsynaptic density immediate-early gene-based network approach

European neuropsychopharmacology, 2016-10, Vol.26, p.S224-S225

2016

Link zum Volltext

Verfügbarkeit prüfen

The novel antipsychotic cariprazine (RGH-188): State-of-the-art in the treatment of psychiatric disorders

European psychiatry, 2016-03, Vol.33 (S1), p.S228-S228

2016

Link zum Volltext

Verfügbarkeit prüfen

P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases

European neuropsychopharmacology, 2016-03, Vol.26, p.S10-S11

2016

Link zum Volltext

Verfügbarkeit prüfen

P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model

European neuropsychopharmacology, 2014-10, Vol.24, p.S519-S519

2014

Link zum Volltext

Verfügbarkeit prüfen

Does the " Silver Bullet " Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients

Clinical practice and epidemiology in mental health, 2016-12, Vol.12 (1), p.142-157

2016

Link zum Volltext

Verfügbarkeit prüfen

Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review

Journal of biological regulators and homeostatic agents, 2014-10, Vol.28 (4), p.795-799

2014

Link zum Volltext

Verfügbarkeit prüfen

K03 Ethical Issues In The Clinical Diagnosis Of Huntington Disease

Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A79-A80

2014

Link zum Volltext

Verfügbarkeit prüfen

P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosis

European neuropsychopharmacology, 2013-10, Vol.23, p.S220-S221

2013

Link zum Volltext

Verfügbarkeit prüfen

Is There a Role for Agomelatine in the Treatment of Anxiety Disorders? A Review of Published Data

International journal of immunopathology and pharmacology, 2013-04, Vol.26 (2), p.299-304

2013

Link zum Volltext

Verfügbarkeit prüfen

A Role for D-aspartate Oxidase in Schizophrenia and in Schizophrenia-related Symptoms Induced by Phencyclidine in Mice

European psychiatry, 2015-03, Vol.30, p.1698-1698

2015

Link zum Volltext

Verfügbarkeit prüfen

P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S341-S342

2012

Link zum Volltext

Verfügbarkeit prüfen

Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions

European psychiatry, 2015-03, Vol.30, p.1754-1754

2015

Link zum Volltext

Verfügbarkeit prüfen

EPA-1116 - Obesity affects cognitive performances even in the absence of obvious psychopathological alterations. a comparison with schizophrenia subjects and non-affected controls

European psychiatry, 2014, Vol.29, p.1-1

2014

Link zum Volltext

Verfügbarkeit prüfen

EPA-1118 - Knowledge of the illness and its relations with quality of life, social functioning, cognitive performances, and adherence in psychotic patients: Toward effectiveness-focused interventions

European psychiatry, 2014, Vol.29, p.1-1

2014

Link zum Volltext

Verfügbarkeit prüfen

2251 – Cortical and subcortical gene-expression imaging by different n-methyl-daspartate receptor (nmda-r) antagonists at glutammatergic synapses: implications for dopamine-glutamate interplay in psychoses

European psychiatry, 2013, Vol.28, p.1-1

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia

European journal of pharmacology, 2012-05, Vol.682 (1-3), p.1-11

2012

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein Level and its Relationship with Suicide Risk and Alexithymia among Newly Diagnosed, Drug-Naïve Patients with Non-Affective Psychosis

European journal of inflammation, 2013-01, Vol.11 (1), p.215-221

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

An update of safety of clinically used atypical antipsychotics

Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients

Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression

A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis

Analysis of Homer1a expression levels as a tool to investigate antipsychotic-related perturbation of synaptic plasticity: translational implications for schizophrenia treatment strategies

Haloperidol modulates functional connectivity in the glutamate system: a postsynaptic density immediate-early gene-based network approach

The novel antipsychotic cariprazine (RGH-188): State-of-the-art in the treatment of psychiatric disorders

P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases

P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model

Does the " Silver Bullet " Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients

Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review

K03 Ethical Issues In The Clinical Diagnosis Of Huntington Disease

P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosis

Is There a Role for Agomelatine in the Treatment of Anxiety Disorders? A Review of Published Data

A Role for D-aspartate Oxidase in Schizophrenia and in Schizophrenia-related Symptoms Induced by Phencyclidine in Mice

P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophrenia

Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions

EPA-1116 - Obesity affects cognitive performances even in the absence of obvious psychopathological alterations. a comparison with schizophrenia subjects and non-affected controls

EPA-1118 - Knowledge of the illness and its relations with quality of life, social functioning, cognitive performances, and adherence in psychotic patients: Toward effectiveness-focused interventions

2251 – Cortical and subcortical gene-expression imaging by different n-methyl-daspartate receptor (nmda-r) antagonists at glutammatergic synapses: implications for dopamine-glutamate interplay in psychoses

Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia

C-Reactive Protein Level and its Relationship with Suicide Risk and Alexithymia among Newly Diagnosed, Drug-Naïve Patients with Non-Affective Psychosis

Suchergebnisse filtern